AC-103

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameAC-103
Drug Alias NameAC103
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbclon Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbclon Inc
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A